Vendor, Seattle, WA
Immunexpress Inc.
UEI KYM8QF1NW567, CAGE 659L3
1 award and $0 obligated between June 18, 2025 and June 18, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50119D00023June 18, 2025, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | EO14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte TechnologyNAICS 541715, PSC AN13 | $0 |
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards